Guideline for the Use of inhaled Nitric Oxide (NO) Catarina Silvestre Prof. Harish Vyas
|
|
- Mervin Bradley
- 5 years ago
- Views:
Transcription
1 Inhaled Nitric Oxide Title of Guideline Guideline for the Use of inhaled Nitric Oxide (NO) 1a 2a 2b Contact Name and Job Title (author) Directorate & Speciality Date of submission October 2015 Date when guideline reviewed October 2018 Guideline Number 1973 Explicit definition of patient group to which it applies (e.g. inclusion and exclusion criteria, diagnosis) Catarina Silvestre Prof. Harish Vyas Directorate: Family Health Children Speciality: Paediatric Intensive Care Patients with Pulmonary Hypertension or ARDS Abstract This guideline describes the indications and the methods for using NO Key Words Paediatrics. Children. Nitric Oxide. Pulmonary hypertension Statement of the evidence base of the guideline has the guideline been peer reviewed by colleagues? meta analysis of randomised controlled x trials at least one well-designed controlled study without randomisation at least one other type of well-designed quasi-experimental study 3 well designed non-experimental descriptive studies (ie comparative / correlation and case studies) 4 expert committee reports or opinions and / or clinical experiences of respected authorities 5 recommended best practise based on the clinical experience of the guideline developer Consultation Process Staff at Nottingham Children s Hospital PICU Target audience PICU staff This guideline has been registered with the trust. However, clinical guidelines are guidelines only. The interpretation and application of clinical guidelines will remain the responsibility of the individual clinician. If in doubt contact a senior colleague or expert. Caution is advised when using guidelines after the review date. Catarina Silvestre Page 1 of 5 October 2015
2 BACKGROUND: Inhaled Nitric oxide (NO) is well established as a highly effective selective pulmonary vasodilator synthesized by the enzyme nitric oxide synthase (NOS) by endothelial cells NO is a gas molecule that diffuses freely from the endothelium to vascular smooth muscle cell, that leads to pulmonary vasodilatation. Nitric oxide is currently used in newborns with Primary Pulmonary hypertension (PPHN) or congenital heart diseases associated pulmonary hypertension. In Paediatric and adults patients, there is no evidence of benefit of NO in acute respiratory syndrome or hypoxic respiratory failure. Despite the improvement of PaO 2 /FiO 2 in the first 4 days of the treatment, there is no reduction in mortality or other outcomes INDICATIONS: Neonatal conditions PPHN Congenital diaphragmatic hernia Neonatal Pulmonary Hypoplasia Pulmonary hypertension in postoperative patient with congenital heart disease Paediatric use Inhaled nitric oxide is not recommended for routine use in paediatric ARDS (PARDS) Its use may be considered in patients with documented pulmonary hypertension or severe right ventricular dysfunction It may be considered in severe cases of PARDS as a bridge to extracorporeal life support. When used, assessment of benefit must be undertaken promptly and serially to minimize toxicity and to eliminate continued ADMINISTRATION: Optimize ventilation: Make sure that the strategy is appropriate for the underlying lung disease Calculate the Oxygenation Index (OI) and record sato 2 Echocardiography is a essential to assess pulmonary artery pressures and for evaluation of right ventricular function Start NO initially at 20 PPM and assess sato 2 After 30 minutes if there is no improvement in OI, STOP the NO Beware of transient drop of SaO 2 due to rebound pulmonary hypertension upon withdrawal. If a patient responds to NO, reduce to the lower effective dose after hours Catarina Silvestre Page 2 of 5 October 2015
3 The required dose of NO will vary from patient to patient. The lowest efficacious dose should be used. Should not be used for greater than 48 hours WEANING: NO may be weaned in a step wise fashion, with a decrement of 5 ppm at a time until 5ppm. Once at 5 ppm it may be desirable to drop 1 ppm each time. At 1 ppm, increase FiO2 by 10% and stop NO. If saturation deteriorates, go back 2-3 ppm and wean 1ppm slowly (NO can be reduced at even slower rate) For the next weaning attempt considerer increasing the FiO % and considerer use of oral phosphodiesterase-5-inhibitor (sildenafil 0,3mg/kg/dose 3-6 hourly, increasing as needed to maximum of 1 mg/kg/dose) NO 20 ppm 30 minutes Improvement PaO 2 / FiO 2 No improvement PaO 2 /FiO 2 STOP NO h 5ppm/ 5ppm 5ppm 1ppm/ 1ppm 1 ppm FiO 2 10% STOP NO Failure to wean: Back to 2-3 ppm Wean slowly until 1ppm Increase FiO % Sildenafil MONITORING Catarina Silvestre Page 3 of 5 October 2015
4 Methemoglobin (MetHb) levels should be recorded 1 and 6 hours after starting and then twice a day.). Half-life of NO is 5 hours Normal range of MetHb: <1-3 % optimal 5-10% reduce NO dose by 50%. >10 % stop NO >20% Methylene blue 1-2 mg/kg IV. NO2 and peroxynitrite: toxic products produced by spontaneous conversion of NO in presence of O 2, or reaction to the presence of free radicals. Clinical trials have stablished low levels of exhaled NO 2, but the effects of NO 2 in poor perfused areas of the lung my cause deleterious effects CONTRAINDICATIONS 1. Methemoglobin reductase deficiency 2. Glucose 6 phosphate dehydrogenase deficiency 3. Neonates dependent on right- to-left shunting of blood Catarina Silvestre Page 4 of 5 October 2015
5 REFERENCES: Barr FE, Macrae D. Inhaled Nitric Oxide and Related Therapies. Pediatr Crit Care Med. 2010; 11(2): S Steinhorn RH. Therapeutic approaches using nitric oxide in infants and children. Radic Biol Med. 2011; 51(5): Adhikari NK, Dellinger RP, Lundin S, Payen D, Vallet B, Gerlach H, Park KJ, Mehta S, Slutsky AS, Friedrich JO. Inhaled Nitric Oxide Does Not reduce Mortality in Patients With Acute Respiratory Distress Syndrome Regardless of Severity: Systemic Review and Meta- Analysis. Crit Care Med. 2014; 42(20): Scheider J, Sweberg T. Acute Respiratory Failure. Crit Care Clin. 2013; 29: Afshari A, Brok J, Møller AM, Wetterslev J. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) and acute lung injury in children and adults (Review). Cochrane Collaboration. 2013; Valentine S, Nadkarni V, Curley M, for the Paediatric Acute Lung Injury Consensus Conference Group. Ped Crit Care Med. 2015;16 (5 Sup):S73-S85 Catarina Silvestre Page 5 of 5 October 2015
USE OF INHALED NITRIC OXIDE IN THE NICU East Bay Newborn Specialists Guideline Prepared by P Joe, G Dudell, A D Harlingue Revised 7/9/2014
USE OF INHALED NITRIC OXIDE IN THE NICU East Bay Newborn Specialists Guideline Prepared by P Joe, G Dudell, A D Harlingue Revised 7/9/2014 ino for Late Preterm and Term Infants with Severe PPHN Background:
More informationAdjunct Therapies for Pediatric ARDS: Where are the Data?
Adjunct Therapies for Pediatric ARDS: Where are the Data? Alexandre T. Rotta, MD, FCCM Professor of Pediatrics, Linsalata Family Endowed Chair in Pediatric Critical Care and Emergency Medicine Rainbow
More informationScope: This guideline is aimed at all Health Care Professionals involved in the care of infants within the Neonatal Service.
Persistent Pulmonary Hypertension of the Newborn (PPHN) University Hospitals of Leicester NHS NHS Trust June 2018 June 2021 Scope: This guideline is aimed at all Health Care Professionals involved in the
More informationSubject: Inhaled Nitric Oxide
07-00007-12 Original Effective Date: 04/15/01 Reviewed: 09/27/18 Revised: 10/15/18 Subject: Inhaled Nitric Oxide THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION, CERTIFICATION, EXPLANATION OF BENEFITS,
More informationKeep. with life MEDICATION TECHNOLOGY SERVICES INSPIRED BY YOUR NEEDS
Keep with life MEDICATION TECHNOLOGY SERVICES INSPIRED BY YOUR NEEDS 2 KINOX MEDICATION KINOX, inhaled nitric oxide, is a selective pulmonary vasodilator developed by Air Liquide Healthcare and characterized
More informationSCVMC RESPIRATORY CARE PROCEDURE
Page 1 of 7 New: 12/08 R: 4/11 R NC: 7/11, 7/12 B7180-63 Definitions: Inhaled nitric oxide (i) is a medical gas with selective pulmonary vasodilator properties. Vaso-reactivity is the evidence of acute
More informationClinical Policy Title: Inhaled nitric oxide
Clinical Policy Title: Inhaled nitric oxide Clinical Policy Number: 11.02.02 Effective Date: June 1 2014 Initial Review Date: February 19, 2014 Most Recent Review Date: May 17, 2017 Next Review Date: March
More informationSWISS SOCIETY OF NEONATOLOGY. Preterm infant with. pulmonary hypertension and hypopituitarism
SWISS SOCIETY OF NEONATOLOGY Preterm infant with pulmonary hypertension and hypopituitarism November 2007 2 Pilgrim S, Stocker M, Neonatal and Pediatric Intensiv Care Unit, Children s Hospital of Lucerne,
More informationNitric Resource Manual
Nitric Resource Manual OBJECTIVES Describe the biologic basis for inhaled nitric oxide therapy Describe the indications for inhaled nitric oxide therapy Describe the potential hazards, side effects and
More informationPolicy #: 440 Latest Review Date: May 2016
Name of Policy: Inhaled Nitric Oxide Policy #: 440 Latest Review Date: May 2016 Category: Therapy Policy Grade: B Background/Definitions: As a general rule, benefits are payable under Blue Cross and Blue
More informationPPHN (see also ECMO guideline)
Children s Acute Transport Service Clinical Guidelines PPHN (see also ECMO guideline) Document Control Information Author P Brooke E.Randle Author Position Medical Student Consultant Document Owner E.
More informationino in neonates with cardiac disorders
ino in neonates with cardiac disorders Duncan Macrae Paediatric Critical Care Terminology PAP Pulmonary artery pressure PVR Pulmonary vascular resistance PHT Pulmonary hypertension - PAP > 25, PVR >3,
More informationClinical Policy Title: Inhaled nitric oxide
Clinical Policy Title: Inhaled nitric oxide Clinical Policy Number: 11.02.02 Effective Date: June 1 2014 Initial Review Date: February 19, 2014 Most Recent Review Date: March 6, 2018 Next Review Date:
More informationSubject: Inhaled Nitric Oxide (ino) for Neonatal Hypoxic Respiratory Failure. Original Effective Date: 10/4/12 10/30/13, 12/16/2015, 7/21/2016
Subject: Inhaled Nitric Oxide (ino) for Neonatal Hypoxic Respiratory Failure Original Effective Date: 10/4/12 Policy Number: MCP-121 Revision Date(s): 10/30/13, 12/16/2015, 7/21/2016 Review Date: 6/22/17
More informationClinical Policy Title: Inhaled nitric oxide
Clinical Policy Title: Inhaled nitric oxide Clinical Policy Number: 11.02.02 Effective Date: June 1 2014 Initial Review Date: February 19, 2014 Most Recent Review Date: March 6, 2018 Next Review Date:
More informationOriginal Policy Date
MP 8.01.17 Inhaled Nitric Oxide Medical Policy Section Therapy Issue 12/2013 Original Policy Date 12/2013 Last Review Status/Date Reviewed with literature search/12/2013 Return to Medical Policy Index
More informationClinical Policy: Inhaled Nitric Oxide Reference Number: CP.MP.87
Clinical Policy: Reference Number: CP.MP.87 Last Review Date: 09/17 Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description (ino) is a
More informationDay care adenotonsillectomy in sleep apnoea
Day care adenotonsillectomy in sleep apnoea Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Day care adenotonsillectomy in presence of sleep apnoea 1a 2a 2b Contact
More informationMEDICAL POLICY I. POLICY POLICY TITLE POLICY NUMBER INHALED NITRIC OXIDE MP-4.021
Original Issue Date (Created): August 23, 2002 Most Recent Review Date (Revised): January 28, 2014 Effective Date: April 1, 2014 I. POLICY Inhaled nitric oxide may be considered medically necessary as
More informationEarlier Use of Inhaled Nitric Oxide in Term and Near-Term Neonates With Hypoxic Respiratory Failure (HRF) and Pulmonary Hypertension (PH)
Earlier Use of Inhaled Nitric Oxide in Term and Near-Term Neonates With Hypoxic Respiratory Failure (HRF) and Pulmonary Hypertension (PH) 2013 Ikaria, Inc. 1 Disclosure Information This program is sponsored
More informationP01. Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) P01 Guideline for Peak flow recording
Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Directorate & Speciality Guideline for Peak flow recording Caroline Youle,
More information** SURFACTANT THERAPY**
** SURFACTANT THERAPY** Full Title of Guideline: Surfactant Therapy Author (include email and role): Stephen Wardle (V4) Reviewed by Dushyant Batra Consultant Neonatologist Division & Speciality: Division:
More informationino_rmp version 4.1_2016 Module Risk-management system NO-RMP-V 2.1
VI.2 Elements for a Public Summary VI.2.1 Overview of disease epidemiology Persistent pulmonary hypertension of the newborn (PPHN) Persistent pulmonary hypertension of the newborn is a life threatening
More informationClinical Policy: Inhaled Nitric Oxide Reference Number: CP.MP.87
Clinical Policy: Reference Number: CP.MP.87 Last Review Date: 09/18 Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description (ino) is a
More informationPulmonary Vasodilator Treatments in the ICU Setting
Pulmonary Vasodilator Treatments in the ICU Setting Lara Shekerdemian Circulation 1979 Ann Thorac Surg 27 Anesth Analg 211 1 Factors in the ICU Management of Pulmonary Hypertension After Cardiopulmonary
More informationManagement of Respiratory Disease in the Term Infant
Management of Respiratory Disease in the Term Infant David Tingay 1. Neonatal Research, Murdoch Children s Research Institute, Melbourne 2. Neonatology, Royal Children s Hospital 3. Dept of Paediatrics,
More informationPERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN East Bay Newborn Specialists Guideline Prepared by L Truong 12/15/2015
PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN East Bay Newborn Specialists Guideline Prepared by L Truong 12/15/2015 Background: Persistent pulmonary hypertension of the newborn occurs in ~2 per 1,000
More informationPFIZER INC. THERAPEUTIC AREA AND FDA APPROVED INDICATIONS: See USPI.
PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. For publications based on this study, see associated bibliography.
More informationNottingham Children s Hospital
High Flow Nasal Cannula Therapy Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Guide line for the use of HFNCT (High Flow Nasal Cannula Therapy) Contact Name
More informationHypoxemia post Liver-Transplantation for Hepatopulmonary Syndrome
! Hypoxemia post Liver-Transplantation for Hepatopulmonary Syndrome HS Jeffrey Man University Health Network and Mount Sinai Hospital Keenan Research Centre at the Li Ka Shing Knowledge Institute, St.
More informationIdiopathic Thrombocytopenic Purpura
Idiopathic Thrombocytopenic Purpura Title of Guideline Contact Name and Job Title (author) Directorate & Speciality Guideline for the management of idiopathic thrombocytopenic purpura Dr S Stokley, Consultant
More information... INOmax Product Information PRODUCT INFORMATION NAME OF THE MEDICINE. INOmax (nitric oxide for inhalation)
PRODUCT INFORMATION NAME OF THE MEDICINE INOmax (nitric oxide for inhalation) Pharmacotherapeutic class: Pulmonary vasodilator DESCRIPTION INOmax (nitric oxide) is a drug administered by inhalation. Nitric
More informationGUIDELINES FOR PERFORMING AN INTRAPERITONEAL UROKINASE LOCK
GUIDELINES FOR PERFORMING AN INTRAPERITONEAL UROKINASE LOCK Contact Name and Job Title (author) Directorate & Speciality Jr Sr Vanessa Keill Diabetes, Infection, Renal and Cardiovascular Directorate (Renal
More informationINOmax Therapy with INOmax DSIR. Linde: Living healthcare
INOmax Therapy with INOmax DSIR are INOmax Therapy 02 We are INOmax Therapy 03 Contents. 4 We are INOmax Therapy 6 INOmax Therapy Mode of action The benefits of INOmax Therapy 18 Efficacy and safety of
More informationMedical Coverage Policy
Medical Coverage Policy Subject: Inhaled Nitric Oxide Policy #: MED Current Effective Date: 11/10/14 Status: New Last Review Date: 11/10/14 Description/Scope Hypoxic respiratory failure may result from
More informationHypoxic Respiratory Failure in the Newborn. Question and Answer
Hypoxic Respiratory Failure in the Newborn Question and Answer Question: When administering nitric oxide to premature babies what is considered safe or common practice in terms of length of treatment?
More information1
1 2 3 RIFAI 5 6 Dublin cohort, retrospective review. Milrinone was commenced at an initial dose of 0.50 μg/kg/minute up to 0.75 μg/kg/minute and was continued depending on clinical response. No loading
More informationIndications Rebound pulmonary hypertension caused by withdrawal of Nitric Oxide in paediatric patients on PICU (unlicensed indication).
Medicines Management & Pharmacy Services (MMPS) Guidelines on the use of sildenafil (Revatio) in acute pulmonary hypertension for paediatric cardiac patients Indications Rebound pulmonary hypertension
More informationPharmacologic Treatment of Neonatal Pulmonary Hypertension
Pharmacologic Treatment of Neonatal Pulmonary Hypertension Steven H. Abman, MD Professor of Pediatrics Director, Pediatric Heart Lung Center University of Colorado School of Medicine and Children s Hospital
More informationExtracorporeal Membrane Oxygenation (ECMO) Referrals
Children s Acute Transport Service Clinical Guideline Extracorporeal Membrane Oxygenation (ECMO) Referrals Document Control Information Author ECMO/CATS Author Position Service Coordinator Document Owner
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT INOmax 400 ppm mol/mol inhalation gas 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Nitric oxide (NO) 400 ppm mol/mol. A 2 litre
More informationInhaled Epoprostenol
PROCEDURE Page 1 of 7 Revised: 06/2018 Purpose The purpose of this guideline is to achieve the following: Establish the safe and effective use of inhaled epoprostenol (PGI2, Flolan) for neonates, pediatrics,
More informationECMO FOR PEDIATRIC RESPIRATORY FAILURE. Novik Budiwardhana * PCICU Harapan Kita National Cardiovascular Center Jakarta
ECMO FOR PEDIATRIC RESPIRATORY FAILURE Novik Budiwardhana * PCICU Harapan Kita National Cardiovascular Center Jakarta Introduction Case D 8 month old baby with severe ARDS with fungal sepsis. He was on
More informationCROSS HEALTH CARE BOUNDARIES MATERNITY CLINICAL GUIDELINE. One
CROSS HEALTH CARE BOUNDARIES MATERNITY CLINICAL GUIDELINE Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Guideline on the Use of the Interpreting Services within
More informationSurfactant Administration
Approved by: Surfactant Administration Gail Cameron Senior Director Operations, Maternal, Neonatal & Child Health Programs Dr. Paul Byrne Medical Director, Neonatology Neonatal Policy & Procedures Manual
More informationInhaled nitric oxide: clinical evidence for use in adults
Inhaled nitric oxide: clinical evidence for use in adults Neill Adhikari Critical Care Medicine Sunnybrook Health Sciences Centre and University of Toronto 31 October 2014 Conflict of interest Ikaria provided
More information3/13/2009. Disclosures. Novel Perioperative Therapies. Rick Barr, MD MSCI Vanderbilt Children s Hospital March 13, 2009
1 Disclosures 2 Novel Perioperative Therapies Rick Barr, MD MSCI Children s Hospital March 13, 29 has filed for patents and licensed citrulline as a therapeutic agent with Asklepion Pharmaceuticals Dr.
More informationCEWT (Children s Epilepsy Workstream in Trent) Guidelines process.
ttingham Children s Hospital ttingham University Hospitals Seizure with Fever Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author)
More informationWeaning strategy with inhaled nitric oxide treatment in persistent pulmonary hypertension of the newborn
F118 Archives of Disease in Childhood 1997;76:F118 F122 Department of Pediatrics, Columbia University, 630 West 168th Street, New York, NY 10032, USA H Aly R Sahni Department of Anesthesia J-T Wung Correspondence
More informationCroup (Laryngo-tracheo-bronchitis)
Croup (Laryngo-tracheo-bronchitis) 1a 2a 2b Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Directorate & Speciality Date of
More informationCardiorespiratory Interactions:
Cardiorespiratory Interactions: The Heart - Lung Connection Jon N. Meliones, MD, MS, FCCM Professor of Pediatrics Duke University Medical Director PCVICU Optimizing CRI Cardiorespiratory Economics O2:
More informationPaediatric addendum to CHMP guideline on the clinical investigations of medicinal products for the treatment of pulmonary arterial hypertension
5 December 2011 EMA/CHMP/213972/2010 Committee for Medicinal Products for Human use (CHMP) Paediatric addendum to CHMP guideline on the clinical investigations of medicinal products for the treatment of
More informationHHS Public Access Author manuscript Semin Perinatol. Author manuscript; available in PMC 2017 October 01.
Inhaled Nitric Oxide Therapy for Pulmonary Disorders of the Term and Preterm Infant Gregory M. Sokol, MD 1, G. Ganesh Konduri, MD 2, and Krisa P. Van Meurs, MD 3 1 Section of Neonatal-Perinatal Medicine,
More informationD. Debray, Hépatologie pédiatrique Hôpital Bicêtre
D. Debray, Hépatologie pédiatrique Hôpital Bicêtre LUNG LIVER GUT AND PORTAL SYSTEM Hepatopulmonary syndrome (HPS) Portopulmonary hypertension (PPH) HEPATOPULMONARY SYNDROME Defect in arterial oxygenation
More informationCardiac Catheter Labs Intravenous Drug Therapy Guide
Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Cardiac Catheter Lab IV Medicines Guideline Helen Buxton ( Senior Cath Lab
More informationInhaled nitric oxide treatment for preterm infants with hypoxic respiratory failure
Thorax 2000;55(Suppl 1):S51 S55 Inhaled nitric oxide treatment for preterm infants with hypoxic respiratory failure Rosalind L Smyth Institute of Child Health, Alder Hey Children s Hospital, Liverpool
More information9/5/2018. Conflicts of Interests. Pediatric Acute Respiratory Distress Syndrome. Objectives ARDS ARDS. Definitions. None
Pediatric Acute Respiratory Distress Syndrome Conflicts of Interests Diane C Lipscomb, MD Director Inpatient Pediatric Medical Director Mercy Springfield Associate Clerkship Clinical Director University
More informationProvide guidelines for the management of mechanical ventilation in infants <34 weeks gestation.
Page 1 of 5 PURPOSE: Provide guidelines for the management of mechanical ventilation in infants
More informationCigna Medical Coverage Policy
Cigna Medical Coverage Policy Subject Inhaled Nitric Oxide (INO) Table of Contents Coverage Policy... 1 General Background... 1 Coding/Billing Information... 16 References... 17 Effective Date... 6/15/2014
More informationPerioperative Management of TAPVC
Perioperative Management of TAPVC Professor Andrew Wolf Rush University Medical Center,Chicago USA Bristol Royal Children s Hospital UK I have no financial disclosures relevant to this presentation TAPVC
More informationWELCOME. Welcome to the Children s Hospital PICU (Pediatric Intensive Care Unit). We consider it a privilege to care for your child and your family.
ECMO FAMILY GUIDE WELCOME Welcome to the Children s Hospital PICU (Pediatric Intensive Care Unit). We consider it a privilege to care for your child and your family. This book was created to give you the
More informationINTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS
Title of guideline (must include the word Guideline (not protocol, policy, procedure etc) INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS Author: Contact Name and Job Title
More informationPAEDIATRIC RESPIRATORY FAILURE. Tang Swee Fong Department of Paediatrics University Kebangsaan Malaysia Medical Centre
PAEDIATRIC RESPIRATORY FAILURE Tang Swee Fong Department of Paediatrics University Kebangsaan Malaysia Medical Centre Outline of lecture Bronchiolitis Bronchopulmonary dysplasia Asthma ARDS Bronchiolitis
More informationBurn Wound Assessment and Infections
Burn Wound Assessment and Infections Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Directorate & Speciality Family Health:
More informationAARC Clinical Practice Guideline
AARC Clinical Practice Guideline Evidence-Based Clinical Practice Guideline: Inhaled Nitric Oxide for Neonates With Acute Hypoxic Respiratory Failure Robert M DiBlasi RRT-NPS FAARC, Timothy R Myers RRT-NPS,
More informationExtracorporeal Membrane Oxygenation (ECMO)
Extracorporeal Membrane Oxygenation (ECMO) Policy Number: Original Effective Date: MM.12.006 05/16/2006 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 01/01/2017 Section: Other/Miscellaneous
More informationDelivery Room Resuscitation of Newborns with Congenital Anomalies
Delivery Room Resuscitation of Newborns with Congenital Anomalies Anne Ades, MD, MSEd Director of Neonatal Education The Children s Hospital of Philadelphia Associate Professor of Clinical Pediatrics Perelman
More informationExtracorporeal Membrane Oxygenation (ECMO)
Extracorporeal Membrane Oxygenation (ECMO) Policy Number: Original Effective Date: MM.12.006 05/16/2006 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 11/01/2014 Section: Other/Miscellaneous
More informationAmy-Jo Hooley Specialist Clinical Pharmacist
Gut Decontamination Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Directorate & Speciality Guideline for the Safe Administration
More informationStaff at the Nottingham Children s Hospital. Guidelines process.
Diabetes and Surgery Title of Guideline Contact Name and Job Title (author) Guideline for the management of children and young people with diabetes aged 18 or under requiring surgery Dr Priyha Santhanam,
More informationThe Blue Baby. Network Stabilisation of the Term Infant Study Day 15 th March 2017 Joanna Behrsin
The Blue Baby Network Stabilisation of the Term Infant Study Day 15 th March 2017 Joanna Behrsin Session Structure Definitions and assessment of cyanosis Causes of blue baby Structured approach to assessing
More informationTitle of Guideline (must include the word Guideline (not protocol, policy, procedure etc)
Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Guideline for the Investigation and Management of Polycystic Ovary Syndrome Author: Contact Name and Job Title
More informationNEONATAL CLINICAL PRACTICE GUIDELINE
NEONATAL CLINICAL PRACTICE GUIDELINE Title: Brain Oxygen Monitoring in Newborns Using Near Infrared Spectroscopy (NIRS) Approval Date: Pages: June 2016 Approved by: Neonatal Patient Care Teams, HSC & SBH
More informationGuidelines and Best Practices for Vapotherm High Velocity Nasal Insufflation (Hi-VNI ) NICU POCKET GUIDE
Guidelines and Best Practices for Vapotherm High Velocity Nasal Insufflation (Hi-VNI ) TM NICU POCKET GUIDE Patient Selection Diagnoses Patient presents with one or more of the following symptoms: These
More informationEPNV-Montreux 2018: Preliminary Educational and Scientific Program
EPNV-Montreux 2018: Preliminary Educational and Scientific Program April 25-26, 2018: Pre-Conference Workshops Wednesday (April 25): 09 00 18 00 Thursday (April 26): 08 00 12 00 April 26-28, 2018: Main
More informationActive Cycle of Breathing Technique
Active Cycle of Breathing Technique Full Title of Guideline: Author (include email and role): Division & Speciality: Version: 3 Ratified by: Scope (Target audience, state if Trust wide): Review date (when
More informationLate pulmonary hypertension in preterm infants How to sort things out? V.Gournay, FCPC, La Martinique, Nov 23,2015
Late pulmonary hypertension in preterm infants How to sort things out? V.Gournay, FCPC, La Martinique, Nov 23,2015 Epidemiology Incidence of extreme prematurity (
More informationARDS: MANAGEMENT UPDATE
ARDS: MANAGEMENT UPDATE Tanıl Kendirli, Assoc. Prof. Ankara University School of Medicine, Pediatric Critical Care Medicine The AECC Definition Timing Acute onset, within 48-72 hours Oxygenation ALI PaO2/FiO2
More informationELIGIBILITY CRITERIA FOR PULMONARY ARTERIAL HYPERTENSION THERAPY
ELIGIBILITY CRITERIA FOR PULMONARY ARTERIAL HYPERTENSION THERAPY Contents Eligibility criteria for Pulmonary Arterial Hypertension therapy...2-6 Initial Application for funding of Pulmonary Arterial Hypertension
More informationECMO for Severe Hypoxemic Respiratory Failure: Pro-Con Debate. Carolyn Calfee, MD MAS Mark Eisner, MD MPH
ECMO for Severe Hypoxemic Respiratory Failure: Pro-Con Debate Carolyn Calfee, MD MAS Mark Eisner, MD MPH June 3, 2010 Case Presentation Setting: Community hospital, November 2009 29 year old woman with
More informationA Clinical Guideline for the use of Intravenous Aminophylline in Acute Severe Asthma in Children
For Use in: By: For: Division responsible for document: Key words: Name and job titles of document author: Name and job title of document author s Line Manager: Supported by: Assessed and approved by the:
More informationSurviving Sepsis Campaign. Guidelines for Management of Severe Sepsis/Septic Shock. An Overview
Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis/Septic Shock An Overview Mechanical Ventilation of Sepsis-Induced ALI/ARDS ARDSnet Mechanical Ventilation Protocol Results: Mortality
More informationLesta Whalen, MD Medical Director, Sanford ECMO Pediatric Critical Care
Lesta Whalen, MD Medical Director, Sanford ECMO Pediatric Critical Care Disclosures I have no financial disclosures. The use of certain devises for providing long-term cardiopulmonary support is investigational.
More informationGuideline for surveillance for hip subluxation and dislocation in children and young people with cerebral palsy. Speciality: General
Title of Guideline Contact Name and Job Title (author) Directorate & Speciality Guideline for surveillance for hip subluxation and dislocation in children and young people with cerebral palsy Janet Corderoy,
More informationIs there a role for Sodium Bicarbonate in NICU? Stephen Wardle Consultant Neonatologist Nottingham University Hospitals
Is there a role for Sodium Bicarbonate in NICU? Stephen Wardle Consultant Neonatologist Nottingham University Hospitals Aim / Objectives To persuade you:- there is no evidence in favour of using bicarbonate
More informationTitle of Guideline (must include the word Guideline (not protocol, policy, procedure etc)
Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Guideline on the management of excessive coumarin anticoagulation in adults
More informationScottish Medicines Consortium
Scottish Medicines Consortium sildenafil, 20mg (as citrate) tablets (Revatio ) No. (596/10) Pfizer Ltd 15 January 2010 The Scottish Medicines Consortium (SMC) has completed its assessment of the above
More informationManagement of refractory ARDS. Saurabh maji
Management of refractory ARDS Saurabh maji Refractory hypoxemia as PaO2/FIO2 is less than 100 mm Hg, inability to keep plateau pressure below 30 cm H2O despite a VT of 4 ml/kg development of barotrauma
More informationThree Decades of Managing Congenital Diaphragmatic Hernia
Three Decades of Managing Congenital Diaphragmatic Hernia Desmond Bohn The Department of Critical Care Medicine The Hospital for Sick Children, Toronto Robert E Gross Congenital Diaphragmatic Hernia 1960-80
More informationCONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEFINITION
CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEFINITION Method of maintaining low pressure distension of lungs during inspiration and expiration when infant breathing spontaneously Benefits Improves oxygenation
More informationNeonatal/Pediatric Cardiopulmonary Care. Persistent Pulmonary Hypertension of the Neonate (PPHN) PPHN. Other. Other Diseases
Neonatal/Pediatric Cardiopulmonary Care Other Diseases Persistent Pulmonary Hypertension of the Neonate (PPHN) PPHN 3 Also known as Persistent Fetal Circulation (PFC) Seen most frequently in term, post-term
More informationInhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients
Journal of Critical Care (2013) 28, 844 848 Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients Heather Torbic PharmD, BCPS a,, Paul M. Szumita PharmD, BCPS
More informationINHALED NITRIC OXIDE AND PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN INHALED NITRIC OXIDE AND PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN
INHALED NITRIC OXIDE AND PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN INHALED NITRIC OXIDE AND PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN JESSE D. ROBERTS, JR., M.D., JEFFREY R. FINEMAN, M.D.,
More informationECMO Primer A View to the Future
ECMO Primer A View to the Future Todd J. Kilbaugh Assistant Professor of Anesthesiology, Critical Care Medicine, and Pediatrics Director of The ECMO Center at the Children s Hospital of Philadelphia Disclosures
More informationHazards and Benefits of Postnatal Steroids. David J. Burchfield, MD Professor and Chief, Neonatology University of Florida
Hazards and Benefits of Postnatal Steroids David J. Burchfield, MD Professor and Chief, Neonatology University of Florida Disclosures I have no financial affiliations or relationships to disclose. I will
More informationDuct Dependant Congenital Heart Disease
Children s Acute Transport Service Clinical Guidelines Duct Dependant Congenital Heart Disease This guideline has been agreed by both NTS & CATS Document Control Information Author CATS/NTS Author Position
More informationnitric oxide for inhalation 100 ppm and 800 ppm Medical Gas
PRODUCT MONOGRAPH Pr Noxivent nitric oxide for inhalation 100 ppm and 800 ppm Medical Gas Praxair Canada Inc. 1 City Centre Drive, Suite 1200, Mississauga, ON L5B 1M2 Control Number: 175320 Date of Preparation:
More informationState of Florida Systemic Supportive Care Guidelines. Michael D. Weiss, M.D. Associate Professor of Pediatrics Division of Neonatology
State of Florida Systemic Supportive Care Guidelines Michael D. Weiss, M.D. Associate Professor of Pediatrics Division of Neonatology I. FEN 1. What intravenous fluids should be initiated upon admission
More informationPro: Early use of VV ECMO for ARDS
Pro: Early use of VV ECMO for ARDS Kyle J. Rehder, MD, FCCP Associate Professor Division of Pediatric Critical Care Medicine Department of Pediatrics Duke Children s Hospital The ventilator is slowly killing
More informationThe use of proning in the management of Acute Respiratory Distress Syndrome
Case 3 The use of proning in the management of Acute Respiratory Distress Syndrome Clinical Problem This expanded case summary has been chosen to explore the rationale and evidence behind the use of proning
More information